Patent · US Active

Facilitation of resuscitation from cardiac arrest by erythropoietin

US8133860B2 · kind B2 · utility

2Cited by

2References

20Claims

0Family size

Assignee

Rosalind Franklin University of Medicine and Science · US

Inventor

Raúl J. Gazmuri · Chicago, US

Key dates

Filing date	Jul 20, 2006
Grant date	Mar 13, 2012
Priority date	—
Expiry date	Jul 20, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates generally to the use of erythropoietin (EPO) to facilitate resuscitation from cardiac arrest. For a mammalian subject suffering from cardiac arrest, concurrent administration of EPO with resuscitation after the onset of ventricular fibrillation facilitates the resuscitation. Administration of EPO serves to attenuate myocardial abnormalities caused by cardiac arrest and the resuscitation efforts and favor improved resuscitation outcomes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.